US 12,408,966 B2
Systems and methods for treating pyronies disease
Csaba Truckai, Saratoga, CA (US)
Assigned to Kemeny Healthcare Inc., San Jose, CA (US)
Filed by Kemeny Healthcare Inc., San Jose, CA (US)
Filed on Jan. 11, 2022, as Appl. No. 17/647,680.
Claims priority of provisional application 63/136,034, filed on Jan. 11, 2021.
Prior Publication US 2022/0218401 A1, Jul. 14, 2022
Int. Cl. A61B 34/10 (2016.01); A61B 18/02 (2006.01); A61B 17/00 (2006.01); A61B 17/34 (2006.01); A61B 18/00 (2006.01); A61B 90/00 (2016.01)
CPC A61B 18/02 (2013.01) [A61B 34/10 (2016.02); A61B 2017/00792 (2013.01); A61B 2017/3413 (2013.01); A61B 2018/00005 (2013.01); A61B 2018/00315 (2013.01); A61B 2018/00642 (2013.01); A61B 2018/00714 (2013.01); A61B 2018/00791 (2013.01); A61B 2018/0293 (2013.01); A61B 2034/105 (2016.02); A61B 2090/378 (2016.02)] 20 Claims
OG exemplary drawing
 
1. A method for cryogenically treating Peyronie's disease, comprising:
providing a cryogenic device including at least one tissue-penetrating needle with a cooling tip;
advancing the cooling tip into plaque in a subject's penile shaft; and
cooling the plaque with the cooling tip thereby inducing a cooling injury to the plaque to achieve a therapeutic effect by reducing curvature of the penile shaft.